Novel,potentandselectiveJNK-1,-2,and-3inhibitor(Ki=0.19µM).SP600125isanATP-competitivereversIBLeinhibitorwith>20-foldselectivityvs.arangeofkinasesandenzymestested.Incells,SP600125causedadose-dependentinhibitionofthephosphorylationofc-Jun,theexpressionofinflammatorygenesIL-2,COX-2,TNF-α,IFN-γ,andblockedtheactivationanddifferentiationofprimaryhumanCD4cellcultures.
≥99%
2.Han,Z.,etal.J.Clin.Invest.108:73-81(2001).